"Phoenix Clinical Research was established in 2006 and is housed in a modern 10,000 square foot facility under the direct supervision of board-certified orthopedic surgeon, Dr. Richard Berkowitz. Dr. Berkowitz has been in private practice since 1996 and has participated in clinical research trials as both a Sub-Investigator and a Principal Investigator. In that time he has performed, or been involved in, over sixty clinical trials and personally oversees every study. The vast majority of patients enrolled in his studies comes from his large personal orthopedic practice and extensive research patient database."

During the past decade, Phoenix Clinical Research, LLC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 13 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenix Clinical Research, LLC" #1 sponsor was "Pfizer" with 3 trials, followed by "Haisco-USA Pharmaceuticals, Inc." with 2 trials sponsored, "Integra LifeSciences Corporation" with 2 trials sponsored, "Pacira CryoTech, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc." with 2 trials sponsored and "PluroGen Therapeutics, Inc" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Clinical Research, LLC" #1 collaborator was "Integrium" with 3 trials as a collaborator, "Arkios BioDevelopment International" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Gulfcoast Research Institute" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Clinical Research, LLC" are "Diabetic Foot Ulcer" (4 trials), "Infection" (2 trials), "Osteoarthritis" (2 trials), "Osteoarthritis, Hip" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Phoenix Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Phoenix Clinical Research, LLC" are "Drug" (23 trials), "Device" (5 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "HSK3486" (2 trials), "Ibuprofen" (2 trials), "Propofol" (2 trials) and "Tanezumab 2.5 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Clinical Research, LLC" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Phoenix Clinical Research, LLC". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Phoenix Clinical Research, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Clinical Research, LLC, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".